Sen. Rand Paul (R-KY) has addressed his failure to report his wife Kelley Paul’s investment in Gilead Sciences, claiming that he did fill out the needed paperwork, but forgot to press send.
Paul filed a disclosure on Wednesday, admitting that his wife purchased stock in Gilead Sciences, which makes an antiviral drug used to treat Covid-19, on Feb. 26, 2020.
The purchase was made before the coronavirus, and its impending impact, was truly understood by the public, and before the World Health Organization even classified it as a pandemic.
News of the purchase was quickly scrutinized, as the Stock Act, created to halt congressional insider trading, requires that such buys be reported within 45 days.
“The senator ought to have an explanation